Guillain-Barre Syndrome Reported After COVID Vaccine

Summary by Cindy Olmstead

A 60-year-old woman with a history of migraines who received the Johnson & Johnson one-dose COVID-19 vaccine developed Guillain-Barré syndrome (GBS) 10 days after receiving the vaccine in a clinical trial in Boston. The patient recovered from GBS after intravenous immunoglobulin (IVIG) treatment, said Dr. Anthony Amato of Harvard Medical School in Boston, adding that it was unlikely the vaccine caused GBS. A test to detect SARS-CoV-2 was repeated twice during the patient’s...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports